Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.


CSE:AIAI - Post by User

Post by yopmemama021on Feb 23, 2022 3:19pm
178 Views
Post# 34455112

MEND

MEND

 $MNNDF

 

$MEND just announced  former COO and President, George Achilleos, will move into the position of CEO to lead the Nurosene team and execution of its strategic plan after Ranj Bath stepped down. 

 

 

Achilleos has led over $50M of business deals / transactions. 

His businesses have generated over $70M of cumulative revenue in the verticals of technology, e-commerce / digital marketing and nanotechnology.

 

as AI in pharma drug developments heads toward becoming the future of the industry I'm looking forward to how Achilleos’ skillset will help establish $MEND as a leader in the space

 

$MEND.C @$0.67 , mc $26.89 M tight share structure of only 40 M OS 

 

https://www.newswire.ca/news-releases/nurosene-announces-a-change-in-leadership-838122328.html

 $MNNDF

 

$MEND just announced  former COO and President, George Achilleos, will move into the position of CEO to lead the Nurosene team and execution of its strategic plan after Ranj Bath stepped down. 

 

 

Achilleos has led over $50M of business deals / transactions. 

His businesses have generated over $70M of cumulative revenue in the verticals of technology, e-commerce / digital marketing and nanotechnology.

 

as AI in pharma drug developments heads toward becoming the future of the industry I'm looking forward to how Achilleos’ skillset will help establish $MEND as a leader in the space

 

$MEND.C @$0.67 , mc $26.89 M tight share structure of only 40 M OS 

 

https://www.newswire.ca/news-releases/nurosene-announces-a-change-in-leadership-838122328.html

 

<< Previous
Bullboard Posts
Next >>